[Early percutaneous coronary angioplasty in unstable angina]

E Rombaut1, C Suilen, P Urban

  • 1Centre de cardiologie, Hôpital cantonal universitaire, Genève, Suisse.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|May 20, 1998
PubMed

Insights

Early percutaneous transluminal coronary angioplasty (PTCA) for unstable angina shows similar success and complication rates compared to delayed procedures. This early intervention significantly reduces hospital stays for patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Unstable angina presents increased risks for percutaneous transluminal coronary angioplasty (PTCA) complications.
  • Pre-procedure medical treatment is common to mitigate thrombosis and dissection risks.
  • A strategy of early coronary angiography and immediate angioplasty is explored.

Purpose of the Study:

  • To evaluate the efficacy and safety of an early interventional approach for unstable angina.
  • To compare outcomes of immediate vs. delayed percutaneous transluminal coronary angioplasty (PTCA).
  • To assess the impact on complication rates and hospital stay duration.

Main Methods:

  • Retrospective review of 853 patients undergoing PTCA for unstable angina (1988-1995).
  • Group I: 402 patients treated on admission day or day after.
  • Group II: 451 patients treated 2 or more days after admission.

Main Results:

  • Similar PTCA success rates in both groups (85.3% vs. 88.2%).
  • Comparable complication rates (death, infarction, bypass surgery) between groups (9.9% vs. 7.3%).
  • Significantly shorter hospital stays for the early intervention group (6.1 vs. 8.7 days).

Conclusions:

  • Early percutaneous transluminal coronary angioplasty (PTCA) in unstable angina is as effective and safe as delayed procedures.
  • An early interventional strategy leads to a significant reduction in hospital length of stay.
  • This approach offers a beneficial alternative for managing unstable angina.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...